Expleo Solutions (EXPLEOSOL)

FairStock Score: 65/100 — STEADY

Score breakdown: P/E: 3/3 · ROCE: 1/2 · Growth: 2/2 · Dividend: 1/1

Key Financials

Strengths

• Low valuation: P/E of 9.98 and dividend yield of 6.63% offer a supportive entry point.
• Strong balance sheet with debt/equity of just 0.03 and Piotroski F-Score of 7/9.
• Capital efficiency is solid: ROE of 15.68% and ROCE of 21.47%.
• Promoter holding of 71.05% aligns management with minority shareholders.
• Large profit growth of 66.38% and PEG of 0.27 suggest the market is not pricing in much optimism.

Concerns

• Sales growth is modest at only 8.45%, so high profit growth may not be sustainable.
• P/B of 2.16 is not cheap against book value of ₹382.76 if returns decline.
• Latest quarter sales of ₹279 Cr and net profit of ₹22 Cr imply thin, possibly volatile margins.
• FairStock Score of 62/100 indicates only steady, not exceptional, business quality.

AI Analysis

At ₹827.55, Expleo Solutions trades at just 9.98 times earnings and offers a dividend yield of 6.63%. That is the sort of number that makes a Graham-style investor sit up. The balance sheet is almost debt-free, with debt/equity of 0.03, and returns are respectable: ROE of 15.68% and ROCE of 21.47%. With promoter holding at 71.05%, my interests are aligned with people who have real skin in the game. A Piotroski score of 7/9 reinforces the picture of financial health. But I must be careful. Sales growth is only 8.45%—this is not a high-growth business. The 66.38% profit growth looks attractive, but I cannot assume it is permanent; one quarter with ₹279 Cr revenue and ₹22 Cr net profit suggests margins could be volatile. If the business can reinvest at 15–20% returns, the book value of ₹382.76 gives a P/B of 2.16—not a deep bargain, but not crazy either. The FairStock Score of 62/100 says steady, not spectacular. In other words, this is a well-run, dull compounder, not a dazzling story. I would call it a Stalwart. The low P/E and high dividend yield provide some margin of safety, but only if the company maintains its returns and does not chase growth at poor prices. I want to see sales growth accelerate or at least stay steady, and profit growth not collapse. The 52-week range of ₹640 to ₹1175 reminds me that markets can be emotional; I prefer buying when fear dominates. At this price, I can be patient, but I would not chase it. Let the figures guide me, not the noise.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer